Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada

BACKGROUND: The emergence of cell-free fetal DNA (cfDNA) testing technology has disrupted the landscape of prenatal screening for trisomies 21 (T21) and 18 (T18). Publicly funded systems around the world are grappling with how to best integrate this more accurate but costly technology, as there is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougan, Shelley D., Okun, Nan, Bellai-Dussault, Kara, Meng, Lynn, Howley, Heather E., Huang, Tianhua, Reszel, Jessica, Lanes, Andrea, Walker, Mark C., Armour, Christine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Joule Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354647/
https://www.ncbi.nlm.nih.gov/pubmed/34344770
http://dx.doi.org/10.1503/cmaj.202456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354647/
https://www.ncbi.nlm.nih.gov/pubmed/34344770
http://dx.doi.org/10.1503/cmaj.202456

Ejemplares similares